Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (sstr4) agonists

Amides de morpholine et de 1,4-oxazepane utilises en tant qu'agonistes du sous-type 4 du recepteur de la somatostatine (sstr4)


The invention relates to morpholine and 1,4-oxazepane amide derivatives of general formula (I), which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture of the compounds according to the invention.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)


Cited By (0)

    Publication numberPublication dateAssigneeTitle